D H Chace1, B W Adam, S J Smith, J R Alexander, S L Hillman, W H Hannon. 1. Neo Gen Screening, 110 Roessler Rd., Pittsburgh, PA 15220. Centers for Disease Control and Prevention (CDC), Newborn Screening Quality Assurance Program, Atlanta, GA 30341-3724, USA.
Abstract
BACKGROUND: Advances in technology and the earlier release of newborns from hospitals have pressed the demand for accurate calibration and improved interlaboratory performance for newborn screening tests. As a first step toward standardization of newborn screening aminoacidopathy tests, we have produced six-pool sets of multianalyte dried-blood-spot amino acid reference materials (AARMs) containing predetermined quantities of five amino acids. We describe here the production of the AARMs, validation of their amino acid contents, and characterization of their homogeneity and their stability in storage. METHODS: To each of six portions of a pool of washed erythrocytes suspended in serum we added Phe (0-200 mg/L), Leu (0-200 mg/L), Met (0-125 mg/L), Tyr (0-125 mg/L), and Val (0-125 mg/L). Six-pool sets (1300) were prepared, dried, and packaged. We used isotope-dilution mass spectrometry to estimate the endogenous amino acid concentrations of the AARMs and validate their final amino acid concentrations. We used additional tandem mass spectrometry analyses to examine the homogeneity of amino acid distribution in each AARM, and HPLC analyses to evaluate the stability of the amino acid contents of the AARMs. RESULTS: The absolute mean biases across the analytic range for five amino acids were 2.8-9.4%. One-way ANOVAs of the homogeneity results predicted no statistically significant differences in amino acid concentrations within the blood spots or within the pools (P >0.05). Regression slopes (0 +/- 0.01) for amino acid concentrations vs storage times and their P values (>0.05) showed no evidence of amino acid degradation at ambient temperatures, 4 degrees C, or -20 degrees C during the intervals tested. CONCLUSION: The validation, homogeneity, and stability of these blood spots support their use as a candidate national reference material for calibration of assays that measure amino acids in dried-blood spots.
BACKGROUND: Advances in technology and the earlier release of newborns from hospitals have pressed the demand for accurate calibration and improved interlaboratory performance for newborn screening tests. As a first step toward standardization of newborn screening aminoacidopathy tests, we have produced six-pool sets of multianalyte dried-blood-spot amino acid reference materials (AARMs) containing predetermined quantities of five amino acids. We describe here the production of the AARMs, validation of their amino acid contents, and characterization of their homogeneity and their stability in storage. METHODS: To each of six portions of a pool of washed erythrocytes suspended in serum we added Phe (0-200 mg/L), Leu (0-200 mg/L), Met (0-125 mg/L), Tyr (0-125 mg/L), and Val (0-125 mg/L). Six-pool sets (1300) were prepared, dried, and packaged. We used isotope-dilution mass spectrometry to estimate the endogenous amino acid concentrations of the AARMs and validate their final amino acid concentrations. We used additional tandem mass spectrometry analyses to examine the homogeneity of amino acid distribution in each AARM, and HPLC analyses to evaluate the stability of the amino acid contents of the AARMs. RESULTS: The absolute mean biases across the analytic range for five amino acids were 2.8-9.4%. One-way ANOVAs of the homogeneity results predicted no statistically significant differences in amino acid concentrations within the blood spots or within the pools (P >0.05). Regression slopes (0 +/- 0.01) for amino acid concentrations vs storage times and their P values (>0.05) showed no evidence of amino acid degradation at ambient temperatures, 4 degrees C, or -20 degrees C during the intervals tested. CONCLUSION: The validation, homogeneity, and stability of these blood spots support their use as a candidate national reference material for calibration of assays that measure amino acids in dried-blood spots.
Authors: B W Adam; E M Hall; M Sternberg; T H Lim; S R Flores; S O'Brien; D Simms; L X Li; V R De Jesus; W H Hannon Journal: Clin Biochem Date: 2011-09-21 Impact factor: 3.281
Authors: J Fachiroh; P R Prasetyanti; D K Paramita; A T Prasetyawati; D W Anggrahini; S M Haryana; J M Middeldorp Journal: J Clin Microbiol Date: 2008-02-06 Impact factor: 5.948
Authors: Dana Boyd Barr; Kurunthachalam Kannan; Yuxia Cui; Lori Merrill; Lauren M Petrick; John D Meeker; Timothy R Fennell; Elaine M Faustman Journal: Environ Res Date: 2021-01-25 Impact factor: 6.498
Authors: Britt Johnson; Hermann Mascher; Daniel Mascher; Elisa Legnini; Christina Y Hung; Angela Dajnoki; Yin-Hsiu Chien; László Maródi; Wuh-Liang Hwu; Olaf A Bodamer Journal: Ann Lab Med Date: 2013-06-24 Impact factor: 3.464
Authors: Stuart J Moat; Danja Schulenburg-Brand; Hugh Lemonde; James R Bonham; Cas W Weykamp; Joanne V Mei; Graham S Shortland; Rachel S Carling Journal: J Inherit Metab Dis Date: 2019-10-02 Impact factor: 4.750